Page last updated: 2024-10-23
bumetanide and Atherosclerotic Parkinsonism
bumetanide has been researched along with Atherosclerotic Parkinsonism in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Lozovaya, N | 1 |
| Eftekhari, S | 1 |
| Cloarec, R | 1 |
| Gouty-Colomer, LA | 1 |
| Dufour, A | 1 |
| Riffault, B | 1 |
| Billon-Grand, M | 1 |
| Pons-Bennaceur, A | 1 |
| Oumar, N | 1 |
| Burnashev, N | 1 |
| Ben-Ari, Y | 1 |
| Hammond, C | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| A Randomized Double-blind Placebo-controlled Multicenter Proof-of-concept Trial to Assess the Efficacy and Safety of Bumetanide in Parkinson's Disease[NCT03899324] | Phase 2 | 40 participants (Anticipated) | Interventional | 2019-04-26 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for bumetanide and Atherosclerotic Parkinsonism